61548-52-5 Usage
Uses
Used in Pharmaceutical Industry:
3-Hydroxy-6-Methyl-2-pyridinecarboxylic acid Methyl ester is utilized as an intermediate in the synthesis of various medicinal compounds, including antibiotics and antiviral drugs. Its unique chemical structure allows it to serve as a key component in the development of new therapeutic agents.
Used in Organic Synthesis:
In the realm of organic synthesis, 3-Hydroxy-6-Methyl-2-pyridinecarboxylic acid Methyl ester functions as a building block for the production of other chemical compounds. Its versatility in chemical reactions makes it a valuable asset in creating a wide range of molecules with diverse applications.
Overall, 3-Hydroxy-6-Methyl-2-pyridinecarboxylic acid Methyl ester holds several important applications in the field of medicine and chemical synthesis, contributing to the advancement of pharmaceutical research and the development of novel compounds with therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 61548-52-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,5,4 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 61548-52:
(7*6)+(6*1)+(5*5)+(4*4)+(3*8)+(2*5)+(1*2)=125
125 % 10 = 5
So 61548-52-5 is a valid CAS Registry Number.
61548-52-5Relevant academic research and scientific papers
CHEMICAL COMPOUNDS-821
-
Page/Page column 64, (2009/03/07)
The invention relates to chemical compounds of the formula (I), or pharmaceutically acceptable salts thereof, which possess ALK5 (TGFβR1) inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the
2 - SUBSTITUTED HETEROCYCLIC COMPOUNDS AND ANTITUMOR COMPOSITION COMPRISING THE SAME
-
Page 22-23, (2010/02/06)
The present invention relates with 2-substituted heterocyclic compounds and antitumor composition comprising the same. The compound according to the present invention exhibits superior effect as telomerase inhibitor based on new mechanism (terlomere-terlomerase) which can resolve the problems occurring at the time of using chemotherapeutics, i.e side effects and cross resistance between related mechanism on using chemotherapeutics. In addition, the antitumor composition comprising the compound of the present invention exhibits superior effect in inhibiting the growth of cancer cell.
